期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Evidence-Based Chinese Medicine Clinical Practice Guideline for Stomach Pain in Hong Kong 被引量:7
1
作者 ZHONG Linda LD SHI Nan-nan +5 位作者 DAI Liang ZIEA Tat Chi NG Bacon TANG Xu-dong BIAN Zhao-xiang LU Ai-ping 《Chinese Journal of Integrative Medicine》 SCIE CAS CSCD 2017年第10期793-800,共8页
Stomach pain in Chinese medicine(CM) is a very common disorder in clinical practice and it has been listed as one of the pilot three conditions in Hong Kong to develop evidence-based CM clinical practice guidelines... Stomach pain in Chinese medicine(CM) is a very common disorder in clinical practice and it has been listed as one of the pilot three conditions in Hong Kong to develop evidence-based CM clinical practice guidelines(CM CPGs). The aim of this stomach Pain CPG is to summarize the treatment methods of stomach pain with CM and evaluate reasonably, then to guide local licensed CM practitioners and provide beneficial reference for social medical decision makers and patients. In this manuscript, we defined stomach pain in CM and the category of chronic gastritis in Western medicine. The clinical manifestation, CM pattern classification, and CM intervention including herbal medicine treatment based on pattern differentiation, symptomatic treatment, acupuncture treatment, regulation and nursing were illustrated. 展开更多
关键词 clinical practice guideline Chinese medicine pattern Chinese herbal medicine stomach pain
原文传递
Use of prostate-specific antigen testing in Medicare beneficiaries:Association with previous evaluation
2
作者 Gregory S.Cooper Tzuyung Doug Kou +3 位作者 Mark D.Schluchter Avi Dor Siran M.Koroukian Simon P.Kim 《Family Medicine and Community Health》 2017年第2期109-118,共10页
Objective:Determine uptake of prostate-specific antigen(PSA)testing in Medicare benefi-ciaries according to previous receipt of PSA testing.Methods:A 5%random sample of men aged 67 years or older without a previous di... Objective:Determine uptake of prostate-specific antigen(PSA)testing in Medicare benefi-ciaries according to previous receipt of PSA testing.Methods:A 5%random sample of men aged 67 years or older without a previous diagnosis of prostate cancer was identified through 2009-2012 Medicare claims.We measured the annualized frequency of PSA screening among men due for PSA testing,stratified by PSA testing use in the previous 2 years,and clustered by ordering provider.Results:Throughout the study period,PSA testing use was consistently higher for men with previous screening than for men without previous screening.For men without previous screening,there was a decline in testing that was most pronounced in 2012.Compared with 2009,the cor-responding odds ratios were 0.98[95%confidence interval(CI)(0.96-1.00)]in 2010,0.94[95%CI(0.92-0.95)]in 2011,and 0.66[95%CI(0.65-0.68)]in 2012.In contrast,for men with previous screening,PSA testing frequency was stable from 2009 to 2011,and declined to a lesser extent in 2012[odds ratio 0.80,95%CI(0.79-0.81)].Conclusion:Receipt of PSA testing is highly dependent on whether an individual was tested in the recent past.In previously unscreened men,the largest decrease occurred in 2012,which may reflect in part the publication of US Preventive Services Task Force guidelines,but there was much less impact among men already being screened. 展开更多
关键词 Prostate-specific antigen MEDICARE mass screening clinical practice patterns
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部